Skip to main content

Advertisement

SpringerLink
Log in

Management of lyme arthritis

  • Original Articles
  • Published:
Comprehensive Therapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention. Case definitions for public health surveillance.MMWR. 1990;39 RR-13:19–21.

    Google Scholar 

  2. Sigal LH. The Lyme disease controversy: the social and financial costs of the mismanagement of Lyme disease.Arch Intern Med. 1996;156:1493–1500.

    Article  PubMed  CAS  Google Scholar 

  3. Sigal LH. Management of Lyme disease refractory to antibiotic therapy.Rheum Dis Clin North Am. 1995;21:217–230.

    PubMed  CAS  Google Scholar 

  4. Sigal LH. Illness behavior and the biomedical model.Bull Rheum Dis. 1997;46:1–4.

    PubMed  CAS  Google Scholar 

  5. Steere A. Lyme disease.N Engl J Med. 1989;321:586–596.

    PubMed  CAS  Google Scholar 

  6. Sigal LH. The immunology and potential mechanisms of immunopathogenesis of Lyme disease.Ann Rev Immunol. 1997;15:63–92.

    Article  CAS  Google Scholar 

  7. White DJ, Chang HG, Benach JL, Bosler EM, Meldrum SC, Means RG, et al. The geographic spread and temporal increase of the Lyme disease epidemic.JAMA. 1991;266:1230–1236.

    Article  PubMed  CAS  Google Scholar 

  8. Matuschka F-R, Endepols S, Richter D, Ohlenbusch A, Eiffert H., Spielman A. Risk of urban Lyme disease enhanced by the presence of rats.J Infect Dis. 1996;174:1108–1111.

    PubMed  CAS  Google Scholar 

  9. Oliver JHJ. Lyme Borreliosis in the southern United States: a review.J Parasitol. 1996;82:926–935.

    Article  PubMed  Google Scholar 

  10. Sackett DL, Richardson WS, Rosenberg W, Haynes RB.Evidence-Based Medicine: How To Practice and Teach EBM. New York: Churchill Livingstone; 1997:250.

    Google Scholar 

  11. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, et al. The early clinical manifestations of Lyme disease.Ann Intern Med. 1983;99:76–82.

    PubMed  CAS  Google Scholar 

  12. Nadelman RB, Wormser GP. Erythema migrans and early Lyme disease.Am J Med. 1995;98:15S-24S.

    Article  PubMed  CAS  Google Scholar 

  13. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut.N Engl J Med. 1996;335:1270–1274.

    Article  PubMed  CAS  Google Scholar 

  14. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, et al. Invasion of the central nervous system byBorrelia burgdorferi in acute disseminated infection.JAMA. 1992;267:1364–1367.

    Article  PubMed  CAS  Google Scholar 

  15. Phillip M, Aydintug MK, Bohm RP, Cogswell FB, Dennis VA, Lanners HN, et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.Infect Immunity. 1993;61:3047–3059.

    Google Scholar 

  16. Garcia-Monco J, Fernandez-Villar B, Alen JC, Benach JL.Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion.J Infect Dis. 1990;161:1187–1193.

    PubMed  CAS  Google Scholar 

  17. Shih C-M, Telford SR, Pollock RJ, Spielman A. Rapid dissemination by the agent of Lyme disease in hosts that permit fulminating infection.Infect Immunity. 1993;61:2396–2399.

    CAS  Google Scholar 

  18. Berger BW. Dermatologic manifestations of Lyme disease.Rev Infect Dis. 1989;11:S1475–1481.

    PubMed  Google Scholar 

  19. Nadelman R, Luger SW, Frank E, et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease.Ann Intern Med. 1992;117:273–280.

    PubMed  CAS  Google Scholar 

  20. Massarotti EM, Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, et al. Treatment of early Lyme disease.Am J Med. 1992;92:396–403.

    Article  PubMed  CAS  Google Scholar 

  21. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler SJ. Clinical and laboratory characteristics of human granulocytic Ehrlichia.JAMA. 1996;275:199–205.

    Article  PubMed  CAS  Google Scholar 

  22. Dumler SJ, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections.Clin Infect Dis. 1995;20:1102–1110.

    PubMed  CAS  Google Scholar 

  23. Pancholi P, Kolbert CP, Mitchell PD, Reed KD, Dumler SJ, Bakken JS, et al.Ixodes dammini as a potential vector of human granulocytic Ehrlichia.J Infect Dis. 1995;172:1007–1012.

    PubMed  CAS  Google Scholar 

  24. Magnarelli L, Dumler JS, Anderson JF, Johnson RC, Fikrig E. Coexistence of antibodies to tick-borne pathogens of Babesiosis, Ehrlichiosis, and Lyme Borreliosis in human sera.J Clin Microbiol. 1995;33:3054–3057.

    PubMed  CAS  Google Scholar 

  25. Walker DH, Barbour AG, Oliver JH, Lane RS, Dumler SJ, Dennis DT, et al. Emerging bacterial zoonotic and vectorborne diseases: ecological and epidemiological factors.JAMA. 1996;275:463–469.

    Article  PubMed  CAS  Google Scholar 

  26. Mitchell P, Reed KD, Hofkes JM. Immunoserologic evidence of co-infection withBorrelia burgdorferi, Babesia microti, and human granulocyticEhrlichia species in residents of Wisconsin and Minnesota.J Clin Microbiol. 1996;34:724–727.

    PubMed  CAS  Google Scholar 

  27. Krause P, Telford SR, Spielman A, Skiand V, Ryan R, Christianson D, et al. Concurrent Lyme disease and Babesiosis: evidence for increased severity and duration of illness.JAMA. 1996;275:1657–1660.

    Article  PubMed  CAS  Google Scholar 

  28. Prueth RK, Marshall WF, Wiltsie JC, Persing DH. Human babesiosis.Mayo Clin Proc. 1995;70:853–862.

    Article  Google Scholar 

  29. Sigal LH. Pseudo-Lyme disease.Bull Rheum Dis. 1995;44:1–3.

    PubMed  CAS  Google Scholar 

  30. Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease.Ann Intern Med. 1980;93:8–16.

    PubMed  CAS  Google Scholar 

  31. Sigal LH. Early disseminated Lyme disease: cardiac manifestations.Am J Med. 1995;98:25S-29S.

    Article  PubMed  CAS  Google Scholar 

  32. Peeters AJ, Dijkmans BAC, Sedney MI. Lyme borreliosis: a hidden cause of heart block in pacemaker treated males. Fourth International Conference on Lyme Borreliosis, Stockholm, Sweden, 1990.

  33. Goodman JL, Sonnesyn SW, Holmer S, Kubo S, Johnson RC. Seroprevalence ofBorrelia burgdorferi in patients with severe heart failure evaluated for cardiac transplant at the University of Minnesota. Fifth International Conference on Lyme Borreliosis, Arlington, Va, 1992.

  34. Pachner AR, Steere AC. The triad of neurological manifestations of Lyme disease.Neurology. 1985;35:47–53.

    PubMed  CAS  Google Scholar 

  35. Garin-Bujadoux C. Paralysie par les Tiques.J Med Lyon. 1922;71:765–776.

    Google Scholar 

  36. Pachner AR. Early disseminated Lyme disease: Lyme meningitis.Am J Med. 1995;98:30S-43S.

    Article  PubMed  CAS  Google Scholar 

  37. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis.Ann Intern Med. 1987;107:725–731.

    PubMed  CAS  Google Scholar 

  38. Steere AC. Musculoskeletal manifestations of Lyme disease.Am J Med. 1995;98:44S-51S.

    Article  PubMed  CAS  Google Scholar 

  39. Steere A, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles.N Engl J Med. 1990;323:219–223.

    PubMed  CAS  Google Scholar 

  40. Sigal LH, Williams S. A monoclonal antibody toBorrelia burgdorferi’s flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for auto-immunity in the neuropathy of Lyme disease.Infect Immunity. 1997;65:1722–1728.

    CAS  Google Scholar 

  41. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.Science. 1998;281:703–706.

    Article  PubMed  CAS  Google Scholar 

  42. Halperin JJ. Neuroborreliosis.Am J Med. 1995;98:52S-59S.

    Article  PubMed  CAS  Google Scholar 

  43. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease.N Engl J Med. 1990;323:1438–1434.

    PubMed  CAS  Google Scholar 

  44. Lesser RL. Ocular manifestations of Lyme disease.Am J Med. 1995;98:60S-62S.

    Article  PubMed  CAS  Google Scholar 

  45. Ilowite NT. Muscle, reticuloendothelial, and late skin manifestations of Lyme disease.Am J Med. 1995;98:63S-68S.

    Article  PubMed  CAS  Google Scholar 

  46. Shrestha M, Grodzicki RL, Steere AC. Diagnosing early Lyme disease.Am J Med. 1985;78:235–240.

    Article  PubMed  CAS  Google Scholar 

  47. Grodzicki R, Steere AC. Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease.J Infect Dis. 1988;157:790–797.

    PubMed  CAS  Google Scholar 

  48. Dattwyler R, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: dissociation of specific T- and B-lymphocyte responses toBorrelia burgdorferi.N Engl J Med. 1988;319:1441–1446.

    PubMed  CAS  Google Scholar 

  49. Magnarelli LA. Current status of laboratory diagnosis for Lyme disease.Am J Med. 1995;98:10S-14S.

    Article  PubMed  CAS  Google Scholar 

  50. Weiss N, Phillips MR, Sadock VA, Sigal LH, Merryman PF, Abramson SB. False positive seroreactivity toB. burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis.Lupus. 1995;4:131–137.

    Article  PubMed  CAS  Google Scholar 

  51. Seltzer E, Shapiro ED. Misdiagnosis of Lyme disease: when not to order serologic tests.Pediatric Infect Dis J. 1996;15:762–763.

    Article  CAS  Google Scholar 

  52. Sigal LH. Pitfalls in the diagnosis and management of Lyme disease.Arthritis Rheum. 1998;41:195–204.

    Article  PubMed  CAS  Google Scholar 

  53. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease.J Infect Dis. 1993;167:392–400.

    PubMed  CAS  Google Scholar 

  54. CDC. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.MMWR. 1995;44:590–591.

    Google Scholar 

  55. Aguero-Rosenfeld M, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response toBorrelia burgdorferi in treated patients with culture-confirmed erythema migrans.J Clin Microbiol. 1996;34:1–9.

    PubMed  CAS  Google Scholar 

  56. Brunner M, Stein S, Sigal LH. Enzyme-linked, IgM capture, immune complex, biotinylated antigen assay (EMIBA): a new serologic assay for early Lyme disease.Arthritis Rheum. 1998;40.

  57. Hassler D, Riedel K, Zorn J, Preac-Mursic V. Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis.Lancet. 1991;338:193.

    Article  PubMed  CAS  Google Scholar 

  58. Sigal LH. Persisting complaints of Lyme disease: a conceptual review.Am J Med. 1994;96:365–374.

    Article  PubMed  CAS  Google Scholar 

  59. Szer IS, Taylor E, Steere AC. The long-term course of Lyme arthritis in children.N Engl J Med. 1991;325:159–163.

    PubMed  CAS  Google Scholar 

  60. Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, DeSanna ET, et al. Treatment of the early manifestations of Lyme disease.Ann Intern Med. 1983;99:22–26.

    PubMed  CAS  Google Scholar 

  61. Butler T.Borrelia species andSpirillum minor. In: Gorbach SL, Bartlett JG, Blacklow NR, eds.Infectious Diseases. Philadelphia, Pa: W.B. Saunders; 1992.

    Google Scholar 

  62. Sigal LH. Use of antibiotics in rheumatologic syndromes.Rheum Dis Clin North Am. 1999. In press.

  63. Gondolf K, Mihatsch M, Curschellas E, Dunn J, Batsford S. Induction of experimental allergic arthritis with outer surface proteins ofBorrelia burgdorferi.Arthritis Rheum. 1994;37:1070–1077.

    Article  PubMed  CAS  Google Scholar 

  64. Sigal LH, Zahradnik JM, Lavin P, Patella SJ, et al. A vaccine consisting of recombinantBorrelia burgdorferi outer-surface protein A to prevent Lyme disease.N Engl J Med. 1998;339:216–222.

    Article  PubMed  CAS  Google Scholar 

  65. Steere AC. Vaccination against Lyme disease with recombinantBorrelia burgdorferi outer-surface lipoprotein A with adjuvant.N Engl J Med. 1998;339:209–215.

    Article  PubMed  CAS  Google Scholar 

  66. Sigal L. Summary of the first one hundred patients seen at a Lyme disease referral center.Am J Med. 1990;88:577–581.

    Article  PubMed  CAS  Google Scholar 

  67. Sigal L, Patella SJ. Lyme arthritis as the incorrect diagnosis in fibromyalgia in children and adolescents.Pediatrics. 1992;90:523–528.

    PubMed  CAS  Google Scholar 

  68. Hsu V, Patella S, Sigal L. “Chronic Lyme disease” as the incorrect diagnosis in patients with fibromyalgia.Arthritis Rheum. 1993;36:1493–1500.

    Article  PubMed  CAS  Google Scholar 

  69. Dinerman H, Steere A. Lyme disease: associated with fibromyalgia.Ann Intern Med. 1992;117:281–285.

    PubMed  CAS  Google Scholar 

  70. Schoen RT, Aversa JM, Rahn DW, Steere AC. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy.Arthritis Rheum. 1991;34:1056–1060.

    Article  PubMed  CAS  Google Scholar 

  71. Haupl T, Hahn G, Rittig M, et al. Persistence ofBorrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme Borreliosis.Arthritis Rheum. 1993;36:1621–1626.

    Article  PubMed  CAS  Google Scholar 

  72. Preac-Mursic V, Patsouris E, Wilske B, Reinhardt S, Gross B, Mehraein P. Persistence ofBorrelia burgdorferi and histopathological alterations in experimentally infected animals. a comparison with histopathological findings in human disease.Infection. 1990;18:332–341.

    Article  PubMed  CAS  Google Scholar 

  73. Lightfoot RJ, Luft BJ, Rahn DW, Steere AC, Sigal LH, Zoschke DC, et al. Treatment of “possible Lyme disease”: a practical policy position of the American College of Rheumatology and the Infectious Disease Society of America based on cost-benefit analysis.Ann Intern Med. 1993;119:503–509.

    PubMed  Google Scholar 

  74. Kuiper H, Deuniese PP, DeJongh BM, Vos K, Dankert J. Absence of Lyme Borreliosis among patients with presumed Bell’s palsy.Arch Neurol. 1992;49:940–943.

    PubMed  CAS  Google Scholar 

  75. Dattwyler RJ, Volkman DJ, Conaty SM, Platkin SP, Luft BJ. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis.Lancet. 1990;ii:1404–1406.

    Article  Google Scholar 

  76. Luft BJ, Dattwyler RJ, Johnson RC, Bosler EM, Rahn DW, Masters EJ, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial.Ann Intern Med. 1996;124:785–791.

    PubMed  CAS  Google Scholar 

  77. Strle F, Preac-Mursic V, Cimperman J, Ruzic E, Maraspin V, Jereb M. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.Infection. 1993;21:83–88.

    Article  PubMed  CAS  Google Scholar 

  78. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme Borreliosis- randomized comparison of ceftriaxone and penicillin.Lancet. 1988;i:1191–1194.

    Article  Google Scholar 

  79. Hassler D, Zoller L, Sonntage MG. Randomized comparative study of cefotaxime versus penicillin G for late Lyme Borreliosis. 16th International Congress on Chemotherapy, Jerusalem, Israel, June 11–16, 1989.

  80. Pfister H-W, Preac-Mursic V, Wilske B, Schielke E, Sorgel F, Einhaupl KM. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis.J Infect Dis. 1991;163:311–318.

    PubMed  CAS  Google Scholar 

  81. Doutlik S, Hancil J, Havlik J. Long-term experience with the treatment of Lyme neuroborreliosis. IV International Conference on Lyme Borreliosis, Stockholm, Sweden, June 18–21, 1990.

  82. Liu NY, Dinerman H, Levin RE, Massarotti E, Molloy PJ, Schoen RT, et al. Randomized trial of doxycycline vs. amoxicillin/Probenecid for the treatment of Lyme arthritis: treatment of non-responders with IV penicillin or ceftriaxone.Arthritis Rheum. 1989;32:S46.

    Google Scholar 

  83. Meissner C, Szer I, Zemel L, Taylor E, Steere A. Amoxicillin or penicillin therapy for Lyme arthritis in children: results from 3 hospitals. IV International Conference on Lyme Borreliosis, Stockholm, Sweden, June 18–21, 1990.

  84. Valesova M, Trnavsky K, Alusik S, Janousek J, Hulinska D, Jirous J. Ceftriaxone in the treatment of Lyme arthritis. IV International Conference on Lyme Borreliosis, Stockholm, Sweden, June 18–21, 1990.

  85. Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.Neurology. 1994;44:1203–1207.

    PubMed  CAS  Google Scholar 

  86. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.N Engl J Med. 1997;337:289–294.

    Article  PubMed  CAS  Google Scholar 

  87. Coblyn JS, Taylor P. Treatment of chronic Lyme arthritis with hydroxychloroquine.Arthritis Rheum. 1981;24:1567–1569.

    Article  PubMed  CAS  Google Scholar 

  88. Bowman MA, Kirk JK, Preisser JS. Use of amantadine for chronic fatigue syndrome.Arch Intern Med. 1997;157:1265–1266.

    Article  Google Scholar 

  89. Heimlich HJ. Should we try malariotherapy for Lyme disease?N Engl J Med. 1990;322:1234–1235.

    PubMed  CAS  Google Scholar 

  90. Edmond MB, Wenzel RP, Pasculle AW. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control.Ann Intern Med. 1996;124:329–334.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tissue Research, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ

    Leonard H. Sigal MD, FACP, FACR (Professor, Department of Medicine, Adjunct Associate Professor, Department of Pediatrics, Chief, Division of Rheumatology and Connective)

Authors
  1. Leonard H. Sigal MD, FACP, FACR
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Sigal, L.H. Management of lyme arthritis. Compr Ther 25, 228–238 (1999). https://doi.org/10.1007/BF02889624

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02889624

Keywords

Search

Navigation